|
|||||
![]() |
|
![]() | |||||||||||||||||||||||||||||
Group: | Order: | Settings | |||||||||||||||||||||||||||
![]() |
No. | Name | Market Cap. | P/E | Forward P/E | PEG | P/S | P/B | P/Cash | P/Free Cash Flow |
Dividend Yield | EPS growth past 5 years | EPS growth next 5 years | Sales growth past 5 years | Float Short | Performance (Week) | Performance (Month) | Performance (Quarter) | Performance (Half Year) | Performance (Year) |
Performance (Year To Date) | Analyst Recom. | Average Volume | Relative Volume | Change | Volume | Number of Stocks |
Overview | Valuation | Performance | Custom | Bar Chart | Spectrum | Charts |
No. | Name | Market Cap | P/E | P/S | P/C | Dividend | Perf Half | Perf Year | Avg Volume | Change | Volume | Stocks |
1 | Communication Services | 5921.66B | 21.42 | 2.41 | 13.36 | 0.93% | -3.88% | -22.73% | 779.49M | 4.05% | 128.88M | 289 |
2 | Consumer Cyclical | 6300.41B | 23.52 | 1.50 | 9.93 | 0.88% | -3.13% | -16.74% | 1.65B | 1.83% | 331.50M | 577 |
3 | Technology | 12088.72B | 28.34 | 4.10 | 16.27 | 0.99% | -4.01% | -15.82% | 1.41B | 2.20% | 226.29M | 789 |
4 | Real Estate | 1582.71B | 25.77 | 4.52 | 25.09 | 3.59% | -3.18% | -12.31% | 313.79M | 1.60% | 22.93M | 270 |
5 | Industrials | 4871.31B | 20.83 | 1.76 | 15.24 | 1.59% | 6.60% | 0.13% | 522.61M | 0.10% | 53.51M | 652 |
6 | Consumer Defensive | 3697.64B | 24.56 | 1.23 | 23.11 | 2.56% | -0.01% | -2.58% | 309.54M | -0.70% | 42.00M | 248 |
7 | Financial | 9353.96B | 14.57 | 2.57 | 0.53 | 2.22% | 8.28% | -8.03% | 850.67M | 0.09% | 89.79M | 1121 |
8 | Basic Materials | 2137.65B | 10.34 | 1.44 | 12.46 | 3.40% | 18.62% | 4.54% | 402.64M | -0.84% | 32.07M | 256 |
9 | Utilities | 1476.35B | 22.10 | 1.78 | 35.33 | 3.45% | -5.99% | 1.02% | 147.02M | -0.11% | 8.29M | 114 |
10 | Healthcare | 7519.49B | 24.58 | 2.00 | 11.81 | 1.57% | 1.00% | -2.02% | 1.19B | -0.56% | 180.91M | 1305 |
11 | Energy | 3632.52B | 7.27 | 0.80 | 10.58 | 6.82% | 11.93% | 19.43% | 544.99M | -0.76% | 32.20M | 268 |
export |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite